Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis

Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory condition of the central nervous system. The extent of disability depends on the severity of the disease and the number of relapses. Although azathioprine is currently the main treatment for patients with NMOSD in Thailand, patients o...

Descripción completa

Detalles Bibliográficos
Autores principales: Aungsumart, Saharat, Apiwattanakul, Metha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015451/
https://www.ncbi.nlm.nih.gov/pubmed/32050011
http://dx.doi.org/10.1371/journal.pone.0229028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015451/
https://www.ncbi.nlm.nih.gov/pubmed/32050011
http://dx.doi.org/10.1371/journal.pone.0229028

Ejemplares similares